Decreased tissue factor expression with increased CD11b upregulation on elastin-based biomaterial coatings.

Area of Science:

• Biomaterials Science
• Immunology
• Surface Chemistry

Background:

• Elastin-like polypeptides (ELPs) are known for their non-thrombogenic properties.
• Understanding ELP interactions with leukocytes is crucial for developing advanced biomaterials.

Purpose of the Study:

• To investigate the interaction of ELP coatings with leukocytes.
• To assess leukocyte activation and platelet-leukocyte aggregation on ELP-coated surfaces.

Main Methods:

• Exposure of citrated whole blood to ELP-coated Mylar™ surfaces under shear conditions.
• Utilizing scanning electron microscopy and flow cytometry to analyze cellular responses.
• Measuring tissue factor (TF), CD61, and CD11b expression as markers for leukocyte activation and aggregation.

Main Results:

• ELP coatings significantly decreased tissue factor (TF) expression by 40% and CD61 expression by 20% in bulk.
• A two- to three-fold increase in CD11b upregulation was observed on ELP-coated surfaces.
• Surface analysis revealed minimal leukocyte activity on uncoated controls.

Conclusions:

• ELP coatings demonstrate a dual effect on leukocyte response, reducing some activation markers while increasing others.
• The findings suggest a complex interaction between ELP coatings and leukocytes, warranting further investigation for biomedical applications.